✓ Verified
Trust score 98/100
Dr Wycliffe Mbagaya
👤 7 years of experience
8,211+
Patients seen
7
Years in practice
13
Publications
2
Languages spoken
About
Dr. Wycliffe Mbagaya is a highly experienced Consultant in Metabolic Medicine, offering private consultations at Nuffield Chesterfield Hospital in Bristol, Spire Bristol Hospital, and 25 Harley Street, London. He also provides virtual consultations for patients seeking expert advice on metabolic and related conditions.
Dr. Mbagaya's medical training began in general medicine, earning Membership of the Royal College of Physicians (MRCP). He then specialized in Chemical Pathology and Metabolic Medicine, achieving Fellowship of the Royal College of Pathologists (FRCPath). He is also recognized as a Specialist in Laboratory Medicine by the European Federation of Clinical Chemistry and Laboratory Medicine.
With an extensive background in metabolism, lipidology, and diabetes, Dr. Mbagaya is one of the few cardiometabolic specialists in the UK. He is committed to providing holistic, patient-centered care and works collaboratively with cardiologists, dietitians, and other specialists to manage complex metabolic conditions. His areas of expertise include cardiometabolic medicine, insulin resistance, cholesterol disorders, electrolyte imbalances, and inherited metabolic diseases.
Dr. Mbagaya has a particular interest in managing patients with conditions such as unexplained fatigue, rare unexplained symptoms, trimethylaminuria (fish odour syndrome), and other malodour syndromes. He frequently advises both patients and healthcare professionals on the interpretation and implications of blood test results. In addition, he is experienced in treating mineral and nutrient deficiencies, such as hypomagnesaemia, phosphate deficiency, and vitamin B12 and vitamin D deficiencies.
An integral part of Dr. Mbagaya's work is his insight into the metabolic effects of various medications, including antidepressants, antipsychotics, chemotherapy, biologics, and immune modulators. He helps optimise patients' metabolic health before surgery, during pregnancy, and throughout the recovery process.
Dr. Mbagaya's clinical practice is particularly valuable for patients with complex, multi-symptom conditions that can remain unexplained for years, such as chronic fatigue, brain fog, and muscle pain. His ability to investigate and manage these symptoms, often related to underlying metabolic diseases, has earned him a strong reputation among both patients and referring doctors.
In addition to his clinical work, Dr. Mbagaya is actively involved in research. He has served as a national chief investigator, principal investigator, and sub-investigator in several groundbreaking studies related to novel cholesterol-lowering medications, some of which are now widely used in clinical practice. He was also an early prescriber of injectable cholesterol medications, GLP-1 agonists, and other newer treatments with cardiometabolic benefits.
Dr. Mbagaya holds a leadership role as Clinical Director for Laboratory Medicine at University Hospitals Bristol and Weston NHS Trust, and he is an Honorary Senior Lecturer at the University of Bristol. He is passionate about teaching and regularly delivers nationwide courses for GPs on metabolic disorders and laboratory medicine, training the next generation of medical professionals.
Specialist Interest:
Cardiometabolic Health
Insulin resistance and Metabolic Syndrome
Rare and complex disorders
High Cholesterol
Stroke prevention
Prediabetes
Peripheral vascular disease
Fatigue
High triglycerides
Vitamin and mineral deficiencies
Carbohydrate and fat dysmetabolism
Metabolic effects of medications
Personalised medicine
Abnormal blood tests
Calcium and Phosphate deficiency
Electrolyte imbalance
Kidney Stone Prevention
Magnesium deficiency
Investigation of fatigue and unexplained symptoms
Trimethylaminuria and Body Odour Syndromes
Metabolic optimisation
Inherited Metabolic Diseases
Vitamin D deficiency
Vitamin B12 deficiency
Metabolic effects of Long COVID
Metabolic effects of menopause
Cardiometabolic risk in women and menopause
Statin intolerance
Long COVID
Heavy metal screening
Fatty liver disease
Metabolic associated liver disease
Testosterone replacement
Metabolic effects of hormone replacement
Specialist metabolic health assessment
Membership:
Royal College of Physicians of Edinburgh
Royal College of Pathologists
Association of Clinical Biochemistry
European Atherosclerosis Society
British Inherited Metabolic Diseases Group
Websites:
https://bloodgenius.co.uk
https://www.metabolicmedicine.co.uk/about
https://www.spirehealthcare.com/consultant-profiles/dr-wycliffe-mbagaya-c6084896
Dr Wycliffe Mbagaya - Phoenix Hospital Group
Dr. Mbagaya's medical training began in general medicine, earning Membership of the Royal College of Physicians (MRCP). He then specialized in Chemical Pathology and Metabolic Medicine, achieving Fellowship of the Royal College of Pathologists (FRCPath). He is also recognized as a Specialist in Laboratory Medicine by the European Federation of Clinical Chemistry and Laboratory Medicine.
With an extensive background in metabolism, lipidology, and diabetes, Dr. Mbagaya is one of the few cardiometabolic specialists in the UK. He is committed to providing holistic, patient-centered care and works collaboratively with cardiologists, dietitians, and other specialists to manage complex metabolic conditions. His areas of expertise include cardiometabolic medicine, insulin resistance, cholesterol disorders, electrolyte imbalances, and inherited metabolic diseases.
Dr. Mbagaya has a particular interest in managing patients with conditions such as unexplained fatigue, rare unexplained symptoms, trimethylaminuria (fish odour syndrome), and other malodour syndromes. He frequently advises both patients and healthcare professionals on the interpretation and implications of blood test results. In addition, he is experienced in treating mineral and nutrient deficiencies, such as hypomagnesaemia, phosphate deficiency, and vitamin B12 and vitamin D deficiencies.
An integral part of Dr. Mbagaya's work is his insight into the metabolic effects of various medications, including antidepressants, antipsychotics, chemotherapy, biologics, and immune modulators. He helps optimise patients' metabolic health before surgery, during pregnancy, and throughout the recovery process.
Dr. Mbagaya's clinical practice is particularly valuable for patients with complex, multi-symptom conditions that can remain unexplained for years, such as chronic fatigue, brain fog, and muscle pain. His ability to investigate and manage these symptoms, often related to underlying metabolic diseases, has earned him a strong reputation among both patients and referring doctors.
In addition to his clinical work, Dr. Mbagaya is actively involved in research. He has served as a national chief investigator, principal investigator, and sub-investigator in several groundbreaking studies related to novel cholesterol-lowering medications, some of which are now widely used in clinical practice. He was also an early prescriber of injectable cholesterol medications, GLP-1 agonists, and other newer treatments with cardiometabolic benefits.
Dr. Mbagaya holds a leadership role as Clinical Director for Laboratory Medicine at University Hospitals Bristol and Weston NHS Trust, and he is an Honorary Senior Lecturer at the University of Bristol. He is passionate about teaching and regularly delivers nationwide courses for GPs on metabolic disorders and laboratory medicine, training the next generation of medical professionals.
Specialist Interest:
Cardiometabolic Health
Insulin resistance and Metabolic Syndrome
Rare and complex disorders
High Cholesterol
Stroke prevention
Prediabetes
Peripheral vascular disease
Fatigue
High triglycerides
Vitamin and mineral deficiencies
Carbohydrate and fat dysmetabolism
Metabolic effects of medications
Personalised medicine
Abnormal blood tests
Calcium and Phosphate deficiency
Electrolyte imbalance
Kidney Stone Prevention
Magnesium deficiency
Investigation of fatigue and unexplained symptoms
Trimethylaminuria and Body Odour Syndromes
Metabolic optimisation
Inherited Metabolic Diseases
Vitamin D deficiency
Vitamin B12 deficiency
Metabolic effects of Long COVID
Metabolic effects of menopause
Cardiometabolic risk in women and menopause
Statin intolerance
Long COVID
Heavy metal screening
Fatty liver disease
Metabolic associated liver disease
Testosterone replacement
Metabolic effects of hormone replacement
Specialist metabolic health assessment
Membership:
Royal College of Physicians of Edinburgh
Royal College of Pathologists
Association of Clinical Biochemistry
European Atherosclerosis Society
British Inherited Metabolic Diseases Group
Websites:
https://bloodgenius.co.uk
https://www.metabolicmedicine.co.uk/about
https://www.spirehealthcare.com/consultant-profiles/dr-wycliffe-mbagaya-c6084896
Dr Wycliffe Mbagaya - Phoenix Hospital Group
“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”
— Dr Wycliffe Mbagaya
Education & training
-
2009–2015 MD · Medicine and Surgery
-
2015–2019 Residency · Chemical Pathology
Career & appointments
-
2019-09–2020-08 Junior consultant
Licenses & insurance
Medical licenses
GB — Organización Médica Colegial de España (OMC)
Board certifications
European Board of Chemical Pathology
Malpractice insurance:
HDI Global · 3,000,000 EUR coverage · No claims on file
Procedures performed
| Procedure | Code | Lifetime count |
|---|---|---|
| GP consultation | 99213 | 2,851 |
| Annual physical exam | 99395 | 1,661 |
| Vaccination administration | 90471 | 1,173 |
| Minor procedure (skin) | 17110 | 1,858 |
Services & pricing
| Service | Duration | Modality | Price |
|---|---|---|---|
| New patient consultation (60m) | 60 min | in_clinic|telemed | 180.00 EUR |
| Follow-up consultation (30m) | 30 min | in_clinic|telemed|phone | 90.00 EUR |
| Vaccination administration | 90 min | in_clinic | 810.00 EUR |
| Minor procedure (skin) | 60 min | in_clinic | 540.00 EUR |
Office, team & in practice
Videos
Research & publications
h-index: 8 · i10: 8
-
Long-term follow-up of Chemical Pathology across GB
DOI: 10.6481/euroclin.2026.0 · PMID: 37606257 · cited by 115
-
Validation of clinical scoring in Chemical Pathology
DOI: 10.1288/euroclin.2025.1 · PMID: 39922950 · cited by 121
Invited talks
- Practical updates in Chemical Pathology European Annual Congress (Chemical Pathology) · Vienna · 2024 · invited
- Single-centre experience in Chemical Pathology National Society Meeting · Bristol · 2023 · oral abstract
Awards & memberships
Awards
- 🏆 Top-rated Chemical Pathology — Bristol · EuroClinics Patient Choice · 2025 · regional
- 🏆 Excellence in Patient Care · National Society · 2024 · national
Society memberships
- WONCA Europe — Family Doctors — Member · Since 2020
- national college of family doctors — Member · Since 2020
- European Union of Medical Specialists (UEMS) — Member · Since 2020
Articles by this doctor
- Patient education Patient guide to Chemical Pathology
- Awareness When should you see a chemical pathology?
For international patients
- Coordinator
- Patient liaison · wycliffe.mbagaya@euroclinics.example
- Accepted international insurance
- Allianz Worldwide · AXA Global · BUPA Global · Cigna Global
Location
1 tagPatient reviews
13 verified reviews5.00
★★★★★
13 reviews
- Bedside Manner
- 5.0
- Knowledge
- 5.0
- Wait Time
- 4.8
- Staff Friendliness
- 5.0
- Ease Of Appointment
- 4.9
- Value For Money
- 4.9
- Would Recommend Pct
- 99.0
Share your experience — help other patients find the right doctor. Write a review →
Recent reviews
-
★★★★★ ✓ Verified Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.
-
★★★★★ ✓ Verified Took time to listen and reviewed all my previous results. I would absolutely recommend.
-
★★★★☆ ✓ Verified Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.
